ACTG to present new HIV and TB research at CROI 2020

(University of California - Los Angeles Health Sciences) ACTG investigators will present data in oral presentations and themed discussions on the impact of chronic antiretroviral therapy (ART) on a novel metric of the HIV reservoir, predictors of multidrug resistant tuberculosis (MDR-TB) in resource-limited settings, findings from the first HIV cure trial that exclusively enrolled women, and interactions between contraceptives and TB drugs and the vaginal microbiome.
Source: EurekAlert! - Infectious and Emerging Diseases - Category: Infectious Diseases Source Type: news